Literature DB >> 14532127

Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.

Tiziana Bonaldi1, Fabio Talamo, Paola Scaffidi, Denise Ferrera, Annalisa Porto, Angela Bachi, Anna Rubartelli, Alessandra Agresti, Marco E Bianchi.   

Abstract

High Mobility Group 1 protein (HMGB1) is a chromatin component that, when leaked out by necrotic cells, triggers inflammation. HMGB1 can also be secreted by activated monocytes and macrophages, and functions as a late mediator of inflammation. Secretion of a nuclear protein requires a tightly controlled relocation program. We show here that in all cells HMGB1 shuttles actively between the nucleus and cytoplasm. Monocytes and macrophages acetylate HMGB1 extensively upon activation with lipopolysaccharide; moreover, forced hyperacetylation of HMGB1 in resting macrophages causes its relocalization to the cytosol. Cytosolic HMGB1 is then concentrated by default into secretory lysosomes, and secreted when monocytic cells receive an appropriate second signal.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532127      PMCID: PMC213771          DOI: 10.1093/emboj/cdg516

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  30 in total

1.  Finding nuclear localization signals.

Authors:  M Cokol; R Nair; B Rost
Journal:  EMBO Rep       Date:  2000-11       Impact factor: 8.807

Review 2.  HMG1 and 2, and related 'architectural' DNA-binding proteins.

Authors:  J O Thomas; A A Travers
Journal:  Trends Biochem Sci       Date:  2001-03       Impact factor: 13.807

Review 3.  New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal.

Authors:  S Müller; P Scaffidi; B Degryse; T Bonaldi; L Ronfani; A Agresti; M Beltrame; M E Bianchi
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

Review 4.  Secretory lysosomes.

Authors:  Emma J Blott; Gillian M Griffiths
Journal:  Nat Rev Mol Cell Biol       Date:  2002-02       Impact factor: 94.444

5.  Thermodynamics of HMGB1 interaction with duplex DNA.

Authors:  S Müller; M E Bianchi; S Knapp
Journal:  Biochemistry       Date:  2001-08-28       Impact factor: 3.162

6.  RanGTP-regulated interactions of CRM1 with nucleoporins and a shuttling DEAD-box helicase.

Authors:  P Askjaer; A Bachi; M Wilm; F R Bischoff; D L Weeks; V Ogniewski; M Ohno; C Niehrs; J Kjems; I W Mattaj; M Fornerod
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

7.  Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes.

Authors:  C Spilianakis; J Papamatheakis; A Kretsovali
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

8.  Acetylation regulates transcription factor activity at multiple levels.

Authors:  E Soutoglou; N Katrakili; I Talianidis
Journal:  Mol Cell       Date:  2000-04       Impact factor: 17.970

9.  High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.

Authors:  U Andersson; H Wang; K Palmblad; A C Aveberger; O Bloom; H Erlandsson-Harris; A Janson; R Kokkola; M Zhang; H Yang; K J Tracey
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

10.  The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells.

Authors:  B Degryse; T Bonaldi; P Scaffidi; S Müller; M Resnati; F Sanvito; G Arrigoni; M E Bianchi
Journal:  J Cell Biol       Date:  2001-03-19       Impact factor: 10.539

View more
  506 in total

Review 1.  HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.

Authors:  Helena Erlandsson Harris; Ulf Andersson; David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2012-01-31       Impact factor: 20.543

2.  Immunomodulatory drugs regulate HMGB1 release from activated human monocytes.

Authors:  Hanna Schierbeck; Heidi Wähämaa; Ulf Andersson; Helena Erlandsson Harris
Journal:  Mol Med       Date:  2010-04-09       Impact factor: 6.354

Review 3.  HMGB1 and microparticles as mediators of the immune response to cell death.

Authors:  David S Pisetsky; Julie Gauley; Anirudh J Ullal
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

4.  Intracellular HMGB1 negatively regulates efferocytosis.

Authors:  Sami Banerjee; Andressa de Freitas; Arnaud Friggeri; Jaroslaw W Zmijewski; Gang Liu; Edward Abraham
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

Review 5.  The dynamics of HMG protein-chromatin interactions in living cells.

Authors:  Gabi Gerlitz; Robert Hock; Tetsuya Ueda; Michael Bustin
Journal:  Biochem Cell Biol       Date:  2009-02       Impact factor: 3.626

6.  Caging a Beast in the Inflammation Arena: Use of Chinese Medicinal Herbs to Inhibit a Late Mediator of Lethal Sepsis, HMGB1.

Authors:  Shu Zhu; Wei Li; Jianhua Li; Andrew E Sama; Haichao Wang
Journal:  Int J Clin Exp Med       Date:  2008-01-20

Review 7.  PKR-dependent inflammatory signals.

Authors:  Rui Kang; Daolin Tang
Journal:  Sci Signal       Date:  2012-10-23       Impact factor: 8.192

8.  HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis.

Authors:  Celine Hernandez; Peter Huebener; Jean-Philippe Pradere; Daniel J Antoine; Richard A Friedman; Robert F Schwabe
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

9.  HMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers.

Authors:  Bilon Khambu; Nazmul Huda; Xiaoyun Chen; Daniel J Antoine; Yong Li; Guoli Dai; Ulrike A Köhler; Wei-Xing Zong; Satoshi Waguri; Sabine Werner; Tim D Oury; Zheng Dong; Xiao-Ming Yin
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

10.  Proinflammatory Effects of Respiratory Syncytial Virus-Induced Epithelial HMGB1 on Human Innate Immune Cell Activation.

Authors:  Kempaiah Rayavara; Alexander Kurosky; Susan J Stafford; Nisha J Garg; Allan R Brasier; Roberto P Garofalo; Yashoda M Hosakote
Journal:  J Immunol       Date:  2018-10-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.